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Abstract: Hyperglycemia and elevation of methylglyoxal (MG) are symptoms of diabetes 
mellitus (DM). In this report, we show that co-treatment of human mononuclear cells 
(HMNCs) with MG (5 μM) and high glucose (HG; 15 – 30 mM) induces apoptosis or 
necrosis. HG/MG co-treatment directly enhanced the reactive oxygen species (ROS) 
content in HMNCs, leading to decreased intracellular ATP levels, which control cell death 
via apoptosis or necrosis. Concentrations of 5 μM MG and 15 mM glucose significantly 
increased cytoplasmic free calcium and nitric oxide (NO) levels, loss of mitochondrial 
membrane potential (MMP), activation of caspases-9 and -3, and cell death. In contrast, no 
apoptotic biochemical changes were detected in HMNCs treated with 5 μM MG and 25 
mM glucose, which appeared to undergo necrosis. Pretreatment with nitric oxide (NO) 
scavengers inhibited apoptotic biochemical changes induced by 5 μM MG/15 mM glucose, 
and increased the gene expression levels of p53 and p21 involved in apoptotic signaling. 
The results collectively suggest that the treatment dosage of MG and glucose determines 
the mode of cell death (apoptosis vs. necrosis) of HMNCs, and that both ROS and NO play 
important roles in MG/HG-induced apoptosis. 
 
Keywords: High glucose; methylglyoxal; apoptosis; ROS; nitric oxide.  
 
OPEN ACCESSInt. J. Mol. Sci. 2009, 10                 
 
 
1446
1. Introduction 
 
Hyperglycemia and increased methylglyoxal (MG) levels, two major symptoms of DM, have long-
term effects on blood and endothelial cells of blood vessels [1, 2]. Previous reports show that high 
glucose (HG) and MG cause various cell injuries, including apoptosis [2-4]. A recent study further 
demonstrates that co-treatment of cells with MG and HG directly evokes ROS generation. The amount 
of ROS generated depends on the treatment dosage, and determines the intracellular ATP level, which 
regulates the cell death mode [5]. Additionally, calcium influx and NO are involved in HG/MG-
induced apoptosis of human umbilical vein endothelial cells (HUVECs) [5]. Both endothelial and 
blood cells may encounter these injury factors in the blood circulation of DM patients. However, the 
combined effects of MG and hyperglycemia in blood cells, and the underlying signaling pathways, 
remain to be elucidated.  
High glucose promotes a hyperosmotic shock environment, leading to osmotic stress that triggers 
various cell responses, including apoptosis [3, 6, 7]. Hyperosmotic shock induces apoptosis through 
multiple biochemical changes, including ROS generation, activation of JNK and caspase-3, and DNA 
fragmentation. These effects are blocked by antioxidants, suggesting that ROS play important roles in 
hyperglycemia-induced apoptosis [3]. Further studies show that HG-induced apoptosis is mediated by 
oxidative stress and JNK activation [2, 3]. However, the effects of the hyperglycemic environment on 
blood cells are yet to be evaluated. 
MG, a reactive dicarbonyl compound formed as a metabolic byproduct of glycolysis, is produced in 
various foodstuffs during processing, including freshly brewed coffee and soy sauce [8]. Coffee is 
highly consumed worldwide, and intake of MG via ingestion of 2-3 cups of coffee can be as much as 1 
mg/day [8]. Moreover, MG levels in diabetics remain elevated for several months, even years. High 
levels of MG are often observed in the blood of diabetic patients, leading to serious toxicological 
effects. Methylglyoxal (MG) is a known metabolic product of glucose. Under hyperglycemic 
conditions, MG is formed from triose phosphate or acetol, and serves as a precursor to advanced 
glycation-end products (AGEs) [9-11]. In diabetic patients, the serum concentration of MG or MG-
derived AGEs is significantly increased compared to that in non-diabetics, and MG has been 
implicated in diabetes-associated diseases including hypertension, retinopathy and nephropathy [12-
14]. Since diabetic complications develop at a slow rate, the long-term effect of MG on AGE 
formation has been investigated in detail [15, 16]. In addition, MG modifies cross-linked lysine and 
arginine residues, altering the protein characteristics and producing reactive oxygen species (ROS) 
during the glycation reaction[17-19]. Oxidative stress and AGE formation are associated with impaired 
cognitive processes in diabetic patients [20, 21], suggesting linkage to MG toxicity. Recent studies 
show that MG induces apoptosis in several cell lines, including Schwann, PC-12, and renal tubular 
cells [22-24]. However, the cytotoxic effects and regulatory mechanisms of MG on blood cells require 
further investigation. 
Numerous chemical and physical treatments capable of inducing apoptosis stimulate oxidative 
stress via generation of ROS in cells [25-27], suggesting a close relationship between oxidative stress 
and apoptosis. Nitric oxide (NO) is an important second messenger involved in a variety cellular 
responses and biological functions, including tumor development, metastasis and apoptosis [28-30]. 
Recent studies demonstrate that NO is largely produced in mitochondria through the actions of a Ca
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sensitive mitochondrial NO synthase (NOS) [31, 32]. NOS-mediated NO production may control 
oxygen consumption and mitochondrial membrane potential through cytochrome c oxidase. The NO 
molecule is subsequently reactivated with superoxide to produce peroxynitrite, further modifying its 
target substrates and inducing oxidative stress [33-35]. Oxidative stress and Ca
2+ influx act as 
upstream regulators of mitochondrial NOS activity [36, 37]. Moreover, our group recently showed that 
MG/HG co-treatment triggers NOS activation, and that NO generation and calcium influx are essential 
for MG/HG-induced apoptosis of HUVECs [5]. However, the biochemical events involved in 
MG/HG-induced cell injury and the regulatory mechanisms in blood cells underlying these effects are 
currently unclear.  
Apoptosis and necrosis, two distinct cell death types, have different biochemical and morphological 
characteristics and regulatory mechanisms [38-42]. Apoptosis plays an important role in the 
embryogenesis and homeostasis of multicellular organisms, and impairment of apoptotic function is 
associated with several human diseases, including neurodegenerative disorders and cancer [43]. In 
contrast, necrosis occurs in response to acute and nonphysiological injury [44]. Recent reports indicate 
that the magnitude of initial insult, and not stimulus type, plays a critical role in prompting cells to 
undergo either necrosis or apoptosis [41, 45, 46]. The ‘choice’ between necrosis and apoptosis is 
possibly controlled by intracellular ATP levels and/or caspase inactivation [47]. In particular, high 
energy levels are required for execution of apoptotic processes, whereas necrosis can proceed in the 
presence of low ATP levels [41, 42, 48, 49]. Here, we focus on the effects of ROS and intracellular 
calcium influx on NO production, and the modulatory effects on cell death modes triggered by 
treatment of HMNCs with a combination of MG/HG. 
 
2. Results and Discussion 
 
To determine the combined effects of MG and hyperglycemia, HMNCs were simultaneously treated 
with MG and HG, and cell viability examined. Importantly, co-treatment with MG and glucose at 
concentrations similar to those detected in the plasma of DM patients (5 μM and 15 mM, respectively) 
decreased cell viability, but not treatment with either agent alone (Figures 1A-D). To determine the cell 
death mode underlying this decreased viability, cellular apoptosis and necrosis were evaluated using 
the TUNEL assay, Propidium Iodide/Hoechst 33342 staining, and LDH activity assay. Interestingly, 
HMNCs treated with 5  μM MG and 15-20 mM glucose showed a marked increase in the apoptotic 
percentage, whereas those treated with 5 μM MG and concentrations of glucose higher than 20 mM 
displayed a significantly increased necrotic cell population (Figures 1E-1G). Our results suggest that a 
co-treatment of HMNCs with MG and HG at concentrations similar to those observed in the blood 
circulation of DM patients promotes injury via apoptotic and necrotic processes. In view of our 
previous findings that numerous stimuli, including MG and HG, trigger apoptosis via ROS generation 
[3, 4], we used DCF-DA and DHR 123 to examine ROS formation in HMNCs co-treated with MG  
and HG.  
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Figure 1. Effects of MG and HG on HMNCs. 
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(A and B) HMNCs were incubated with 0 – 30 mM glucose (A) or 0 – 160 μM MG (B) for 24 h. 
Cell viability was determined using the MTT assay. (C-G) HMNCs were treated with or without 
MG (5 μM) and various concentrations of glucose for 24 h. Total cell numbers after treatment were 
measured by trypan blue staining (C). Cell viability was measured (D). Apoptosis was detected 
with the Cell Death Detection ELISA kit (E), followed by staining with propidium iodide and 
Hoechst 33342 (F). Necrosis was further assessed in terms of LDH activity released in the culture 
medium, with data expressed as a percentage of the maximal level (Max) of LDH activity 
determined after total cell lysis (G). (H). HMNCs were incubated with N-acetyl cysteine (NAC; 
300 μM), L-NMMA (400 μM), PTIO (20 μM) and EGTA (500 μM) for 24 h. Cell viability was 
determined using the MTT assay. Values are presented as means ± SD of eight determinations. *P < 
0.05, **P < 0.01 and ***P < 0.001 versus the untreated control group. 
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A combination of 5 μM MG and 15 – 30 μM HG stimulated ROS generation about 5.5 – 11-fold, 
compared to the untreated control group (Figure 2A). Interestingly, pretreatment with N-acetylcysteine 
(NAC), a commonly used ROS scavenger, effectively prevented ROS generation by 5 μM MG and 15 
mM glucose, and partially blocked ROS production by 5 μM MG and 25 mM glucose (Figure 2B). 
Furthermore, NAC pretreatment inhibited cell apoptosis induced by 5 μM MG/15 mM glucose, and 
shifted the mode of cell death stimulated by 5 μM MG/25 mM glucose from necrosis to apoptosis 
(Figure 2C). These results suggest that the ROS content participates in determining the cell death mode 
of MG/HG-treated HMNCs.  
 
Figure 2. MG/HG co-treatment promotes oxidative stress in HMNCs. 
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(A) HMNCs were treated with or without MG (5 μM) and various concentrations of glucose for 24 
h. ROS generation was assayed using DCF-DA (20 μM) or dihydrorhodamine 123 (DHR 123; 20 
μM) dye. (B and C) HMNCs were pre-incubated with N-acetyl cysteine (NAC; 300 μM) for 30 min, 
followed by treatment with or without MG and glucose, as indicated. ROS generation was assayed 
using DCF-DA dye (B). The percentage of apoptosis or necrosis (C) was measured, as described in 
Figure 1. Data are representative of eight independent experiments. ***P < 0.001 versus the 
untreated control group. #P < 0.001 versus the “MG + HG (15 mM)” group. §P < 0.001 versus the 
“MG + HG (25 mM)” group. 
 
We previously demonstrated that the ATP level is an important mediator capable of switching the 
mode of cell death from apoptosis to necrosis [41]. To further elucidate the mechanism by which 
MG/HG triggers either apoptotic or necrotic processes, we examined the ATP content in MG/HG-
treated HMNCs. Treatment of HMNCs with 5 μM MG and 20 – 30 mM glucose induced a decrease in Int. J. Mol. Sci. 2009, 10                 
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the ATP level, whereas 5 μM MG and 5 – 15 mM glucose had no effect on the cellular ATP content 
(Figure 3A). To further clarify the role of intracellular ATP levels in MG/HG-induced apoptosis or 
necrosis, we examined the cell death modes of ATP-depleted cells. HMNCs were treated with 
antimycin (a mitochondrial inhibitor), which causes ATP depletion (Figure 3B) or left untreated, and 
the modes of MG/HG-induced cell death examined. Pretreatment of cells with antimycin led to switch 
of apoptosis induced by 5 μM MG and 15 mM HG to necrosis, and enhanced 5 μM MG and 25 mM 
glucose-stimulated necrosis (Figure 3C). Moreover, NAC pretreatment effectively blocked the 5 μM 
MG and 25 mM glucose-induced decrease in ATP levels, and induced a subsequent switch from 
necrosis to apoptosis (Figures 3B and 3C), suggesting that the ROS content mediates intracellular ATP 
levels and modulates the associated switch between apoptosis and necrosis in MG/HG-treated HMNCs. 
 
Figure 3. MG/HG co-treatment induces a decrease in intracellular ATP levels. 
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(A) HMNCs were treated with MG (5 μM) and various concentrations of glucose for 24 h. 
Intracellular ATP levels were determined using a bioluminescence-based ELISA assay. Data are 
presented as a percentage of untreated controls, and values as means ± SD of five determinations. 
(B and C) HMNCs were incubated with antimycin (2 μM) or NAC (300 μM) for 1 h, followed by 
treatment with MG and glucose, as indicated, for a further 24 h. ATP levels (B) and percentage of 
cell apoptosis or necrosis (C) were measured. The given values are representative of eight 
determinations. ***P < 0.001 versus the untreated control group. #P < 0.001 versus the “MG + HG 
(15 mM)” group. §P < 0.001 versus the “MG + HG (25 mM)” group. 
 
Changes in [Ca
2+]i in MG/HG-treated HMNCs were detected using the Fluo-3AM fluorescence 
dye. Treatment with 5 μM MG and 15 mM glucose elicited an increase in [Ca
2+]i, but not 5 μM MG 
and 25 mM glucose (Figure 4A). Furthermore, cells cultured in Ca
2+-containing medium displayed a 
~2.7-fold increase in [Ca
2+]i following treatment with 5 μM MG and 15 mM glucose, while no effects 
were evident on cells cultured in Ca
2+-free culture medium (Figure 4A). These findings indicate that Int. J. Mol. Sci. 2009, 10                 
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the rise in [Ca
2+]i is primarily attributed to the influx of internal Ca
2+, such as that observed in the 
endoplasmic reticulum, mitochondria, nucleus and/or calcium-binding proteins (Figure 4A).  
PTIO, an inhibitor of NOS and scavenger of NO, and L-NMMA, an inhibitor of NO synthase 
(NOS), had little effect on the [Ca
2+]i increase induced by 5 μM MG and 15 mM glucose, whereas 
pretreatment with NAC significantly suppressed this increase (Figure 4B). These results suggest that 
elevation of [Ca
2+]i induced by 5 μM MG/15 mM glucose is regulated by ROS, but not NO. We 
further employed the NO-sensitive dye, DAF-2DA, to measure intracellular NO generation during 
MG/HG-induced apoptosis. Intracellular NO levels were increased in HMNCs co-treated with 5 μM 
MG and 15 mM glucose (Figure 4C). However, this increase was prevented upon pretreatment of cells 
with the NOS inhibitor, L-NMMA (Figure 4C) or 500 μM EGTA (a Ca
2+ chelator) (Figure 4C). Our 
results suggest that intracellular Ca
2+ levels play an important role in NOS activation and NO increases 
observed in HMNCs co-treated with 5 μM MG and 15 mM glucose.  
 
Figure 4. MG/HG co-treatment triggers changes in intracellular calcium and NO content in 
HMNCs. 
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(A) HMNCs were incubated with MG and glucose, as indicated, for 24 h. Intracellular Fluo-3 
fluorescence intensity was measured in the presence/absence of extracellular Ca
2+. (B) Intracellular 
Ca
2+ level changes triggered by co-treatment with MG (5 μM) and HG (15 mM), and effects of 
ROS and NO inhibitors (NAC: 300 μM; L-NMMA: 400 μM; PTIO: 20 μM). (C) HMNCs were 
pretreated with L-NMMA (400 μM) or EGTA (500 μM) for 30 min, followed by incubation with or 
without MG (5 μM) and HG (15 mM). Intracellular NO generation was measured using the DAF-
2DA fluorescence dye. Data are presented as a percentage of the control group. ***P < 0.001 
versus the untreated control group. #P < 0.001 versus the “MG + HG” group. 
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Next, we analyzed changes in MMP, a major apoptotic event during mitochondrial-mediated 
apoptosis. Uptake of DiOC6(3) and TMRE into mitochondria of HMNCs was observed, indicating a 
significant loss of MMP following co-treatment with 5 μM MG and 15 mM glucose, which trigger 
apoptotic processes, but not 5 μM MG and 25 mM glucose, which induce necrotic processes (Figure 
5A). In addition, we monitored activation of caspases-9 and -3 involved in mitochondrial-mediated 
apoptotic pathways. Treatment of HMNCs with 5 μM MG and 15 mM glucose stimulated the 
activation of caspases-9 (Figure 5B) and -3 (Figure 5C), but not 5 μM MG and 25 mM glucose. 
Importantly, both loss of MMP and caspases activation were significantly inhibited upon incubation of 
cells with 20 μM PTIO, prior to co-treatment with 5 μM MG and 15 mM glucose (Figures 5A-5C). 
These results indicate that the increase in the NO level may act as an upstream regulator of MMP 
changes and activation of caspase-9 and -3 during MG/HG-induced apoptosis, but not necrosis   
of HMNCs.  
 
Figure 5. MMP changes and activation of caspase-9 and -3 following MG/HG treatment  
of HMNCs. 
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Data from real-time RT-PCR analyses revealed significant upregulation of p53 and p21 mRNA in 
HMNCs co-treated with 5 μM MG and 15 mM glucose, which was blocked by pretreatment with NAC 
or PTIO (Figures 6A and B).  
 
Figure 6. Effects of NAC and PTIO on the mRNA levels of p53 and p21. 
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To further determine the roles of p53 and p21 in MG/HG-induced apoptosis, we used targeted 
siRNAs to suppress p53 expression in HMNCs. Cells were incubated with 5 μM MG and 15 mM 
glucose for 24 h, and tested for viability. Knockdown with p53 siRNA led to a significant decrease in 
the mRNA levels of p53 and p21 in MG/HG-treated HMNCs (Figure 7A), which was associated with 
a marked decrease in MG/HG-induced apoptosis (Figure 7B). These results suggest that MG/HG 
combination treatment upregulates p53 and p21 in HMNCs, subsequently promoting apoptosis of 
treated cells.  
 
Figure 7. Knockdown of p53 protects HMNCs against MG/HG-induced apoptosis. 
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HMNCs were transfected with siRNA targeting p53, incubated for 24 h, and treated with MG (5 
μM) and HG (15 mM) for a further 24 h. (A) The mRNA levels of p53 and p21 were analyzed 
using real-time PCR. (B) Cell apoptosis was measured as described in Figure 1. ***P < 0.001 
versus the untreated control group. #P < 0.001 versus the “MG + HG” group. 
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Increased concentrations of MG and glucose in blood are two major symptoms of DM. We 
previously showed that treatment with glucose at concentrations higher than 25 mM triggers apoptotic 
processes in K562 cells, a human leukemia cell line [3], and 250 μM MG causes various cells injuries, 
including apoptosis [4]. In addition, while the injury effects of MG/HG on HUVECs and the precise 
signaling cascades of cell death have been investigated [5], the influence of MG/HG on blood cells, 
particularly white blood cells involved in the immune defense system of DM patients, are unclear at 
present. Our present results indicate that glucose alone at concentrations higher than 25 mM and MG 
alone at concentrations higher than 40 μM induce a decrease in cell viability of HMNCs (Figures 1A 
and 1B). However, since hyperglycemia and increased MG levels are observed simultaneously in DM 
patients, we investigated the effects of co-treatment with MG and glucose. Co-treatment of HMNCs 
with 5 μM MG and 15 – 30 mM HG stimulated a significant decrease in cell viability (Figure 1D). 
Furthermore, within this range, the glucose concentration determined whether cell death occurred via 
apoptosis or necrosis (Figures 1E-G).  
Earlier studies demonstrate that HG promotes ROS generation in human aortic endothelial [50] and 
K562 cells [3], and triggers apoptosis in HMNCs [51]. Additionally, a recent investigation shows that 
intracellular ROS is generated upon MG treatment of mouse embryonic stem cells [4]. MG treatment 
can increase intracellular ROS levels in several ways: (1) the glycation reaction of amino acids or 
proteins with MG can produce ROS (such as O2
-); (2) metabolism of MG may deplete the cells’ 
glutathione content, thereby decreasing the elimination of intracellular ROS; and/or (3) ROS scavenger 
enzymes, such as superoxide dismutases, glutathione peroxidases and glutathione transferases, may be 
modified/inactivated by MG [17, 52, 53]. In addition, our recent studies have demonstrated that high 
MG levels may be the main cause of immune dysfunction in diabetic patients [18, 19]. We monitored 
DNA strand breakage, ROS generation and oxidative DNA damage induced in vitro by a 50 μM 
MG/lysine glycation reaction (3 h) in HMNCs. Our results revealed that oxidative stress and DNA 
damage were directly induced by 50 μM MG/lysine, indicating that oxidative stress plays a role in 
MG-induced cell injury [18]. Importantly, our group previously reported that methylglyoxal and high 
glucose synergistically trigger ROS generation to stimulate downstream apoptotic biochemical 
changes [5]. The present results disclose that co-treatment with MG/HG stimulates ROS generation to 
a higher extent than MG or HG alone (data not shown), implying that MG/HG act synergistically to 
produce ROS. The ROS generation mechanisms of methylglyoxal and high glucose are distinct. 
Mechanisms underlying the effects of a combination of MG/HG on ROS generation are more complex 
than those of MG and HG alone, and are under investigation in our laboratory at present. However, 
cells treated with 5 μM MG and co-treated with concentrations of glucose higher than 15 mM 
displayed significantly increased ROS generation (Figure 2A). The ROS content in these cells aided in 
determining whether subsequent cell death proceeded through apoptosis or necrosis (Figure 2C). These 
results signify that MG and glucose synergistically cooperate to promote ROS generation and cell 
apoptosis or necrosis.  
Chemically induced hypoxia activates distinct types of cell death, depending on the intensity of the 
stimulus or triggering insult in rat fibroblastic cells [54]. Apoptosis was predominant in cells treated 
with low doses of antimycin A, a specific inhibitor of the mitochondrial respiratory chain, while 
necrosis was increasingly favored with increasing intensity of hypoxic insult [54]. Other studies 
suggest that the intracellular ATP level represents an important regulator of the switch to apoptosis or Int. J. Mol. Sci. 2009, 10                 
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necrosis [41, 47, 49, 54], with necrosis favored under low ATP conditions in many model systems. 
Consistent with this theory, several studies show that high ATP levels are essential for nuclear 
morphologic changes characteristic of apoptosis [55]. Previously, we showed that 50 – 200 μM and 
12.5 – 25 μM curcumin induced two distinct cell death programs in osteoblasts. In this system, 
curcumin decreased the intracellular ATP levels in osteoblasts in a dose-dependent manner, leading to 
an effective switch from apoptosis to necrosis [41]. According to these results, higher ROS generation 
induced lower intracellular ATP levels and necrotic death, while lower ROS levels during apoptotic 
stimulus treatment allowed cells to maintain a higher ATP level that induced cell death via apoptotic 
processes. In the present study, we show that the ROS content of MG/HG-treated HMNCs affects the 
intracellular ATP levels and aids in determining the mode of induced cell death (Figure 3). Previous 
findings, in conjunction with the present results, support the theory that the ROS content and ATP 
level act as the switch for determining whether MG/HG-induced cell death in HMNCs proceeds 
through apoptosis or necrosis.  
Intracellular calcium levels play an important role in regulation of cell death [31, 56, 57]. In this 
investigation, we determine whether the MG/HG combination induces apoptosis through intracellular 
calcium increase. We observed an increase in [Ca
2+]i following MG/HG treatment, which was largely 
attributed to influx of internal Ca
2+  storage organelles (Figures 4A and 4B). This effect was 
significantly blocked by NAC (Figure 4B), indicating that MG/HG-induced ROS generation is 
responsible for elevation of intracellular calcium concentrations in treated HMNCs.  
NO is an endogenous product of NADPH, O2 and L-arginine catalyzed by nitric oxide synthase. A 
recent study demonstrates that NO is involved in apoptosis triggered by several types of stimuli [31, 
32]. The regulatory actions of NO on the mitochondrial apoptotic signaling pathways are well 
documented. Decreased ratios of Bcl-2/Bax and inhibition of electron transport are regulatory 
mechanisms of NO-mediated apoptosis [58]. A decrease in the Bcl-2/Bax ratio and impairment of 
mitochondrial electron transport may cause release of cytochrome c involved in the control of cell 
apoptosis. Additionally, tamoxifen enhanced the intramitochondrial Ca
2+ concentration, leading to 
stimulation of mitochondrial NO synthase activity and NO production in rat livers and human breast 
cancer MCF-7 cells [32]. Here, we observed NO generation following MG/HG treatment of HMNCs, 
with ~ 3.1-fold higher intracellular NO levels in treated cells versus untreated controls (Figure 4C). 
Pretreatment with EGTA prevented this increase in intracellular NO to a marked extent (Figure 4C), 
indicating that NO production in MG/HG-treated HMNCs is dependent on the intracellular calcium 
concentration. The regulatory role of NO in cell apoptosis is complex, and several studies show that 
NO-mediated apoptotic effects are modulated by different mechanisms in distinct cell types [30, 59]. 
NOS substrates or NO donors inhibit photodynamic treatment-induced apoptosis in CCRF-CEM cells 
[60]. In our experiments, PTIO attenuated loss of MMP and decreased caspases activation (Figure 5), 
suggesting that NO is an important mediator of apoptosis in MG/HG-treated HMNCs. 
NO-mediated apoptotic processes are associated with p53 gene activation, which is essential for 
regulation of the cell cycle and/or apoptotic signaling occurring through p21
Waf1/Cip1 or Bax [61, 62]. 
Here, we show upregulation of both p53 and p21 mRNA expression following treatment with MG/HG, 
which was blocked upon pretreatment with PTIO and NAC (Figure 6). The p53 protein, which is the 
expression product of the p53 tumor suppressor gene, prevents cell with damaged DNA from 
proliferating. The damaged DNA triggers the activation of an enzyme called ATM kinase, which Int. J. Mol. Sci. 2009, 10                 
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catalyzes the phosphorylation of p53 proteins. Accumulation of phosphorylated p53 proteins in a 
DNA-damaged cell can activate two types of events: cell cycle arrest and cell apoptosis. The p53 
protein is a transcription factor that can activate specific genes, including the p21 gene. The p21 
protein, a member of the Cdk inhibitor, can block the activation of the Cdk-cycline complex, thereby 
causing cell cycle arrest. The p53 protein can also activate genes encoding proteins that can trigger cell 
apoptotic processes through binding and inactivation of the Bcl2 protein, an inhibitor of apoptosis. In 
the present study, we found that siRNA-mediated knockdown of p53 mRNA prevented the MG/HG-
induced up-regulation of p21 mRNA expression, and decreased subsequent apoptosis (Figures 7A and 
B). These results indicate that p53 and p21 are activated during MG/HG-induced apoptosis of 
HMNCs. We hypothesize that, in MG/HG-treated HMNCs, generated ROS may trigger DNA damage, 
thereby activating p53 and triggering downstream apoptotic signal cascades. However, future studies 
will be required to examine the precise regulatory roles of p53 and p21 in MG/HG-induced apoptosis  
of HMNCs. 
 
3. Conclusions 
 
Co-treatment with MG/HG causes cell death (apoptosis or necrosis) in HUVECs [5]. However, no 
injury effects are observed upon treatment with MG or HG alone. Here, we further confirm this 
synergistic injury effect of MG/HG in blood cells.  
 
Figure 8. Scheme of events occurring during MG/HG-induced cell death in HMNCs. 
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It is possible that injury of DM patients affects endothelial cells of blood vessels and blood cells of 
circulation. However, the injury effects of MG/HG on DM patients in vivo require further Int. J. Mol. Sci. 2009, 10                 
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investigation. Based on the results of the present study, we propose a possible model of MG/HG-
induced cell injury signaling in HMNCs (Figure 8). Co-treatment of cells with MG and HG directly 
induces ROS, with the treatment dosage affecting the amount of ROS generated. The ROS content 
determines intracellular ATP levels, which regulate cell death, with high ATP levels favoring 
apoptosis and low ATP levels favoring necrosis. In addition, high levels of intracellular ROS trigger an 
influx of calcium from the intracellular Ca
2+ storage organelles, leading to increased intracellular 
calcium concentrations that stimulate NO generation. Pretreatment with NAC or PTIO blocks the 
MG/HG-induced up-regulation of critical genes, and rescues cell viability. Our results collectively 
demonstrate that both intracellular ROS and NO play critical roles in MG/HG-induced apoptosis   
of HMNCs. 
 
4. Experimental Section 
 
4.1. Materials 
 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 2-phenyl-4,4,5,5-tetra-
methylimidazoline-1-oxyl-3-oxide (PTIO), N-acetylcysteine (NAC), 2’,7’-dichlorofluorescein 
diacetate (DCF-DA), propidium iodide, Hoechst 33342 and ethyleneglycol-bis(β-
aminoethylether)tetraacetic acid (EGTA) were purchased from Sigma (St. Louis, MO). Z-DEVD-AFC 
was obtained from Calbiochem (La Jolla, CA). 
 
4.2. Isolation of human mononuclear cells (HMNCs) and treatment 
 
Blood was collected from 30 healthy humans (15 males and 15 females, all 20 years of age) who 
reported no history of smoking, allergies, and medication and alcohol consumption. Mononuclear cells 
were isolated from 50 mL aliquots of human blood using Histopaque 1077 [63]. The samples were 
centrifuged at 400 × g for 30 min, and HMNCs were collected from the interface and resuspended in 
Tris-buffered saline (20 mM Tris, 0.15 M NaCl, pH 7.4). The cells were sedimented by centrifugation 
at 300 × g for 15 min and then resuspended in RPMI. Isolated HMNCs from different humans were 
pooled and randomly selected for experiments. For experiments, cells were incubated with medium 
containing the indicated concentrations of MG and glucose. High glucose treatment was performed by 
incubating cells in medium containing various concentrations of glucose (5 – 30 mM) for 24 h. The 
osmolarity of medium (an isotonic solution) was 300 mosmol/kg. Following the addition of 5 – 30 mM 
glucose into the medium, the osmolarity of this hypertonic solution was altered to 305 – 330 
mosmol/kg. The MG/HG co-treated cells were washed twice with ice-cold phosphate-buffered saline 
(PBS) and lysed on ice for 10 min in 400 μL lysis buffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 
mM EGTA, 1% Triton
® X-100, 1 mM benzamidine, 1 mM phenylmethyl-sulfonyl fluoride, 50 mM 
NaF, 20 μM sodium pyrophosphate and 1 mM sodium orthovanadate). The cell lysates were sonicated 
on ice for 3 × 10 sec and centrifuged at 15,000 × g for 20 min at 4
oC, and the supernatants were used 
as cell extracts. Int. J. Mol. Sci. 2009, 10                 
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4.3. MTT assay 
 
Cell survival was monitored using the MTT (3-[4,5-dimethylthiazol-2-yl] -2,5-diphenyltetrazolium 
bromide) test. Briefly, cells were treated with the indicated concentrations of MG and glucose for 24 h, 
and then treated with 100 μL of 0.45 g/L MTT solution. The cells were incubated at 37
oC for 60 min to 
allow color development, and then 100 μL of 20% SDS in DMF:H2O (1:1) solution was added to each 
well to stop the reaction. The plates were incubated overnight at 37
oC for solubilization of the 
formazan products, and spectrophotometric data were measured using an ELISA reader at a 
wavelength of 570 nm. 
 
4.4. Assessment of necrosis and apoptosis 
 
Oligonucleosomal DNA fragmentation (a hallmark of apoptosis) was measured using the Cell 
Death Detection ELISA
plus kit (Roche Molecular Biochemicals, Mannheim, Germany). Cells (1 × 10
5) 
were treated with or without the indicated concentrations of MG and glucose at 37
 oC for 24 h, the 
procedures were performed according to the manufacturer’s protocol, and spectrophotometric data 
were obtained using an ELISA reader at 405 nm. In addition, cells were incubated with propidium 
iodide (1 μg/mL) and Hoechst 33342 (2 μg/mL) at room temperature for 10 min, and fluorescent 
microscopy was used to identify the percentage of propidium iodide-impermeable cells having 
condensed/fragmented nuclei (apoptotic) and the percentage of propidium iodide-permeable cells 
(necrotic). In each experiment, 8 – 10 independent fields (~ 500 – 800 nuclei in total) were counted per 
condition. The activity of lactate dehydrogenase (LDH) present in the culture medium was evaluated 
as an additional index of necrosis, as previously described [18, 42, 64, 65]. Briefly, cells (5 × 10
4) 
were cultured in 96-well microtiter plates (100 μL medium/well), LDH activity was assayed using, and 
the absorption values at 490 nm were determined with an ELISA reader, according to the 
manufacturer’s instructions (Promega, Madison, WI). Blanks consisted of test substances added to 
cell-free medium. 
 
4.5. ROS assay 
 
ROS were measured in arbitrary units using 2’,7’-dichlorofluorescein diacetate (DCF-DA) or 
dihydrorhodamine 123 (DHR 123) dye. Cells (1.0 × 10
6) were incubated in 50 μL PBS containing 20 
μM DCF-DA or DHR123 for 1 h at 37
oC, and relative ROS units were determined using a 
fluorescence ELISA reader (excitation 485 nm, emission 530 nm). An aliquot of the cell suspension 
was lysed, the protein concentration was determined, and the results were expressed as arbitrary 
absorbance units/mg protein.  
 
4.6. ATP level analysis 
 
Cells treated with the indicated concentrations of MG and glucose were collected, and ATP levels 
were quantified with an ATP determination kit. Cells were collected by centrifugation, resuspended in 
distilled water and then boiled for 5 min. The ATP level in each extract was determined by a Int. J. Mol. Sci. 2009, 10                 
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bioluminescence assay using a liquid scintillation analyzer, according to the manufacturer’s protocol 
(Molecular Probes, Eugene, OR).  
 
4.7. Detection of intracellular calcium concentration ([Ca
2+]i ) 
 
The [Ca
2+]i was detected with Fluo-3 AM fluorescence dye, using a modification of the previously 
reported method [31, 66]. Briefly, cells were co-treated with MG and glucose, harvested and washed, 
and then loaded with 6 μM Fluo-3 AM in standard medium (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 
5.6 mM glucose, 1.5 mM CaCl2, and 20 mM Hepes, pH of 7.4). After 30 min, the cells were washed 
three times with PBS and then resuspended in standard medium or Ca
2+-free standard medium. The 
fluorescence intensity of Fluo-3 was determined using a fluorescence spectrophotometer (Hitachi, F-
2000; excitation at 490 nm, emission at 526 nm).  
 
4.8. Detection of intracellular NO content 
 
The DAF-2DA fluorescence dye was used to detect intracellular NO, according to a modification of 
the previously reported method [31, 67]. Briefly, treated or control cells were collected and washed, 
and then incubated with 3 μM DAF-2DA. After 60 min, the cells were washed three times with PBS 
and the fluorescence intensity was measured by a fluorescence spectrophotometer (Hitachi, F-2000; 
excitation at 485 nm, emission at 515 nm). 
 
4.9. Caspase activity assays 
 
Caspase-9 activity was assayed using the Colorimetric Caspase-9 Assay Kit (Calbiochem, CA). 
Caspase-3 activity was measured using the Z-DEVD-AFC fluorogenic substrate, as previously 
described [68, 69]. 
 
4.10. Real-time RT-PCR assay 
 
Total RNA was extracted with the TRIzol reagent (Life Technologies) and purified with an RNeasy 
Mini kit (Qiagen), according to the manufacturers’ protocols. Real-time PCR was carried out with an 
ABI 7000 Prism Sequence Detection System (Applied Biosystems). The β-actin mRNA levels were 
quantified as an endogenous control, and used for normalization. The primers used for PCR were as 
follows: p53, 5′-CCC ATC CTC ACC ATC ATC AC-3′ and 5′-GTC AGT GGG GAA CAA GAA 
GTG-3′; p21, 5′-GCC GAA GTC AGT TCC TTG TGG A-3′ and 5′-GTG GGC GGA TTA GGG  
CTT-3′. 
 
4.11. siRNA knockdown 
 
Lipofectamine was used to transfect mononuclear cells with 150 nM of siRNA for targeting against 
p53 (5'-GACUCCAGUGGUAAUCUACTT-3'; sip53) or a scrambled control duplex (5'-
GCGCGCUUUGUAGGAUUCG-3'; siScr). Twenty-four hours post-transfection, fresh culture Int. J. Mol. Sci. 2009, 10                 
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medium was added, and the cells were treated with or without 5 μM MG and 15 mM glucose for 
another 24 h.  
 
4.12. Statistics 
 
Data were analyzed using one-way ANOVA, and differences were evaluated using a two tailed 
Student’s t-test and analysis of variance. P < 0.05 was considered significant. 
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